Speakers

Nathan Grubaugh joined the faculty at Yale School of Public Health in 2018. Before graduate school, he spent seven years in the biotech industry developing early-phase vaccine candidates. He earned his MS in Biotechnology from Johns Hopkins University (2011), conducting research at the NIH and the U.S. Army Research Institute of Infectious Diseases, with a focus on mosquito-borne virus surveillance. He earned his PhD in Microbiology from Colorado State University in 2016, focusing on West Nile virus evolution, then completed a postdoctoral fellowship at The Scripps Research Institute studying the 2015–2017 Zika virus epidemic. At Yale, the Grubaugh Lab uses genomics and phylogenetics to uncover the epidemiological, ecological, and evolutionary drivers of virus outbreaks, with a focus on mosquito- and tick-borne viruses—such as dengue, West Nile, and Powassan—that are spreading into new areas and pose significant outbreak risk. The lab is multidisciplinary, with expertise spanning molecular biology, phylogenetics, statistics, and mathematical modeling. His lab is also an academic partner for the Pathogen Genomics Centers of Excellence, advancing innovation in pathogen genomics, molecular epidemiology, and bioinformatics to better prevent and respond to public health threats.